NanoComposix is a nanotechnology development and contract manufacturing organization (CMO) and has been manufacturing nanomaterials for biotech clients under current good manufacturing practices (cGMP) since 2017.
The company recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
Dedicated to manufacturing nanomaterial-based medical devices and drugs, the facility includes a qualified ISO 8 cleanroom.
According to the company, “the capability of manufacturing drugs in-house ensures nanoComposix' growing number of clients have the flexibility to utilize one vendor throughout the product life cycle.”
Founder and President Dr. Steve Oldenburg said in a statement: "This opens up a new set of capabilities for our clients and allows us to align with our long-term corporate goal of supplying nanotechnology enabled products from concept through commercialization."
Since 2004, NanoComposix has been providing development, fabrication, processing, and scale-up services to commercialize nanomaterials in several applications, including in vitro diagnostics, therapeutics, devices, plasmonic, and preclinical drugs.
